Differential regulation of H3K9/H3K14 acetylation by small molecules drives neuron-fate-induction of glioma cell
暂无分享,去创建一个
Z. Fan | Jun Hu | K. Sai | Guangmei Yan | Tian-dong Leng | Wenbo Zhu | Jing Cai | Yuan Lin | Wei Yin | Yingqiang Zhong | Jie-Si Chen | Cui Guo | Jingyi Wang | Jialuo Mai | Jiayu Gu | Bin Jiang | Jiankai Liang | Shu-xin Sun | Zhijie Chen | W. Yang | Xincheng Liu | Qianyi Li | Jinhai Xu | Wenzhuo Yang | Jingyi Wang | Xuanming Liang | Chaoxin Chen | W. Yang | Tiandong Leng | Wenzhuo Yang
[1] I. Simon,et al. Mitotic H3K9ac is controlled by phase-specific activity of HDAC2, HDAC3, and SIRT1 , 2022, Life Science Alliance.
[2] Xin-cheng Liu,et al. Disruption of β-catenin-mediated negative feedback reinforces cAMP-induced neuronal differentiation in glioma stem cells , 2022, Cell Death & Disease.
[3] C. Harms,et al. The Effects of Selective Inhibition of Histone Deacetylase 1 and 3 in Huntington’s Disease Mice , 2021, Frontiers in Molecular Neuroscience.
[4] V. Madan,et al. Differentiation therapy of myeloid leukemia: four decades of development , 2020, Haematologica.
[5] Sandra Reyes-Carmona,et al. Histone H3K9 and H3K14 acetylation at the promoter of the LGALS9 gene is associated with mRNA levels in cervical cancer cells , 2020, FEBS open bio.
[6] X. Wan,et al. Small Molecules that Promote Self-Renewal of Stem Cells and Somatic Cell Reprogramming , 2020, Stem Cell Reviews and Reports.
[7] Xiang Zhuang,et al. Correction: HDAC3 Deficiency Promotes Liver Cancer through a Defect in H3K9ac/H3K9me3 Transition. , 2020, Cancer research.
[8] Irina M. Bochkis,et al. Hdac3, Setdb1, and Kap1 mark H3K9me3/H3K14ac bivalent regions in young and aged liver , 2019, bioRxiv.
[9] Gary D Bader,et al. Pathway enrichment analysis and visualization of omics data using g:Profiler, GSEA, Cytoscape and EnrichmentMap , 2019, Nature Protocols.
[10] T. Jiang,et al. A radiomic signature as a non-invasive predictor of progression-free survival in patients with lower-grade gliomas , 2018, NeuroImage: Clinical.
[11] Y. Takeda,et al. Chemical compound-based direct reprogramming for future clinical applications , 2018, Bioscience reports.
[12] S. Legartová,et al. HDAC1 and HDAC3 underlie dynamic H3K9 acetylation during embryonic neurogenesis and in schizophrenia-like animals , 2017, Journal of cellular physiology.
[13] A. Hao,et al. Effect of melatonin on neuronal differentiation requires CBP/p300-mediated acetylation of histone H3 lysine 14 , 2017, Neuroscience.
[14] Lisa C. Wallace,et al. Targeting Glioma Stem Cells through Combined BMI1 and EZH2 Inhibition , 2017, Nature Medicine.
[15] Liwu Fu,et al. Targeting VCP enhances anticancer activity of oncolytic virus M1 in hepatocellular carcinoma , 2017, Science Translational Medicine.
[16] Yinsheng Chen,et al. Glioblastoma stem cell differentiation into endothelial cells evidenced through live-cell imaging , 2017, Neuro-oncology.
[17] Xiaobai Zhang,et al. Nucleosome eviction along with H3K9ac deposition enhances Sox2 binding during human neuroectodermal commitment , 2017, Cell Death and Differentiation.
[18] Shiyuan Cheng,et al. The Anti-Warburg Effect Elicited by the cAMP-PGC1α Pathway Drives Differentiation of Glioblastoma Cells into Astrocytes , 2017, Cell reports.
[19] B. Xue,et al. Histone Deacetylase 1 (HDAC1) Negatively Regulates Thermogenic Program in Brown Adipocytes via Coordinated Regulation of Histone H3 Lysine 27 (H3K27) Deacetylation and Methylation* , 2016, The Journal of Biological Chemistry.
[20] L. Panasci,et al. Interferon-α/β enhances temozolomide activity against MGMT-positive glioma stem-like cells. , 2015, Oncology reports.
[21] Qing-Yu He,et al. ChIPseeker: an R/Bioconductor package for ChIP peak annotation, comparison and visualization , 2015, Bioinform..
[22] R. Momparler,et al. Targeting of cancer stem cells by inhibitors of DNA and histone methylation , 2015, Expert opinion on investigational drugs.
[23] E. Nestler,et al. Antidepressant action of HDAC inhibition in the prefrontal cortex , 2015, Neuroscience.
[24] N. Jing,et al. Dual roles of histone H3 lysine 9 acetylation in human embryonic stem cell pluripotency and neural differentiation. , 2015, The Journal of Biological Chemistry.
[25] Jill S Barnholtz-Sloan,et al. Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution , 2015, Genome research.
[26] T. Qian,et al. Localizing seizure-susceptible brain regions associated with low-grade gliomas using voxel-based lesion-symptom mapping. , 2015, Neuro-oncology.
[27] J. Brotchie,et al. RGFP109, a histone deacetylase inhibitor attenuates L-DOPA-induced dyskinesia in the MPTP-lesioned marmoset: a proof-of-concept study. , 2013, Parkinsonism & related disorders.
[28] Justin Guinney,et al. GSVA: gene set variation analysis for microarray and RNA-Seq data , 2013, BMC Bioinformatics.
[29] H. Kimura,et al. H3K9 and H3K14 acetylation co-occur at many gene regulatory elements, while H3K14ac marks a subset of inactive inducible promoters in mouse embryonic stem cells , 2012, BMC Genomics.
[30] K. Aldape,et al. Induction of cell-cycle arrest and apoptosis in glioblastoma stem-like cells by WP1193, a novel small molecule inhibitor of the JAK2/STAT3 pathway , 2012, Journal of Neuro-Oncology.
[31] Yan Li,et al. Transcriptional and post‐transcriptional down‐regulation of cyclin D1 contributes to C6 glioma cell differentiation induced by forskolin , 2011, Journal of cellular biochemistry.
[32] Weiqi Zhang,et al. Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules , 2011, Cell Research.
[33] P. Farnham,et al. Using ChIP-seq technology to identify targets of zinc finger transcription factors. , 2010, Methods in molecular biology.
[34] A. Ganesan,et al. Epigenetic therapy: histone acetylation, DNA methylation and anti-cancer drug discovery. , 2009, Current cancer drug targets.
[35] Yan Li,et al. Cholera toxin induces malignant glioma cell differentiation via the PKA/CREB pathway , 2007, Proceedings of the National Academy of Sciences.
[36] T. Theoharides,et al. Mast cells, T cells, and inhibition by luteolin: implications for the pathogenesis and treatment of multiple sclerosis. , 2007, Advances in experimental medicine and biology.
[37] D. Sterner,et al. Acetylation of Histones and Transcription-Related Factors , 2000, Microbiology and Molecular Biology Reviews.